IngentaConnect Profound weight loss associated with reboxetine use in a 44-year-...

Authors: Lu, T. Y.-T.¹; Kupa, A.²; Easterbrook, G.³; Mangoni, A. A.

Source: British Journal of Clinical Pharmacology, Volume 60, Number 2, August 2005 , pp. 218-220(3)

Publisher: Blackwell Publishing

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

We report a case of significant weight loss experienced by a 44-year-old Caucasian woman treated with reboxetine. She was treated with this drug at 12 mg daily for a total duration of 11 months. During the corresponding period her body mass index (BMI) decreased from a baseline of 21.4 kg m^-2 to a low of 16.8 kg m^-2. Withdrawal of the drug led to a full recovery of her BMI. The strongest evidence linking reboxetine to this woman's weight loss laid in the fact that the re-introduction of the drug subsequently caused a similar negative impact in her BMI.

Keywords: Reboxetine; weight loss; adverse drug reactions

Document Type: Research article

DOI: 10.1111/j.1365-2125.2005.02407.x

Affiliations: 1: Clinical Pharmacology & Centre for Neuroscience, 2: Immunology, and 3: Pharmacy, Flinders Medical Centre and Flinders University, Adelaide, Australia

You have access to the full text article on a website external to Ingentaconnect.

Please click here to view this article on Synergy.

You may be required to register and activate access on Synergy before you can obtain the full text. If you have any queries please contact onlinehelp@oxon.blackwellpublishing.com

Profound weight loss associated with reboxetine use in a 44-year-old woman